Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Indices trade with significant cuts; pharma share advance for 3rd day
At 14:28 IST, the barometer index, the S&P BSE Sensex advanced 403.55 points or 0.53% to 77,206.46. The Nifty 50 index rose 118.05 points or 0.50% to 24,132.45.
Mcap of 9 most valued firms jumps ₹2.15 trn, Airtel biggest winner
The combined market valuation of nine of the top-10 most valued firms jumped by Rs 2.15 lakh crore last week, with Bharti Airtel emerging as the biggest winner, in line with improving global risk sentiment. Last week, the BSE benchmark Sensex jumped 1,274.95 points, or 1.68 per cent. "Indian equity markets extended their recovery during the week, supported by easing geopolitical concerns, softer crude oil prices, and improving global risk sentiment. Although negotiations remain ongoing and the agreement is yet to be fully implemented, the reduction in geopolitical uncertainty has significantly improved market sentiment," Ponmudi R, CEO - Enrich Money, an online trading and wealth tech firm, said. The market valuation of Bharti Airtel surged by Rs 52,432.67 crore to Rs 11,62,963.30 crore, the most among the top-10 firms. Life Insurance Corporation of India (LIC) added Rs 51,675.23 crore, taking its valuation to Rs 5,56,726.30 crore. The valuation of Bajaj Finance soared by Rs 26,55
Nifty extends winning streak to fifth day; banks, healthcare stocks lead gains
The S&P BSE Sensex advanced 254.36 points or 0.33% to 77,409.98. The Nifty 50 index rose 82.30 points or 0.34% to 24,168. In five sessions, the Sensex jumped 4.85% and Nifty climbed 4.35%.
Sensex Today | Stock Market LIVE Updates: Nifty, Sensex set for muted open; Anthem Biosciences in focus
Sensex Today | Stock Market LIVE Updates:Today is the weekly expiry of all BSE contracts. The recent phase for the market has been a good one, with the Nifty having recovered 1,000 points from last week's low of 23,070. A close above 24,000 is also a positive.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
KIMS launches ₹1,500 crore QIP to repay debt and fund subsidiaries
KIMS has launched a ₹1,500 crore qualified institutions placement (QIP) through a 100% primary share issuance, with the indicative price set at ₹755 per share at up to a 3% discount to the last closing price. The hospital chain plans to use the proceeds to repay debt and fund investments in its subsidiaries, with the issue expected to be priced later this week and listed on the NSE and BSE thereafter.
INR surges amid sharp pull back in oil prices; Sensex and Nifty jump by around 2%
The Indian rupee surged 67 paise to close at 95.18 (provisional) against the greenback on Friday as global oil prices fell sharply after US President Donald Trump indicated an imminent deal with Iran. A firm trend in domestic equity markets and a weaker American currency also supported the rupee during the day. Indian shares closed Friday's session on a buoyant note in a broad-based rally, with both frontline and broader market indexes posting sharp gains. The BSE Sensex settled at 75,527.95, surging 1,695.40 points (2.30%), and the NSE Nifty50 ended at 23,622.90, climbing 461.30 points (1.99%). Trump has reportedly said a deal to end the war with Iran is nearly complete, and is expected to be signed over the weekend in Europe, as he called off military strikes on the Islamic Republic hours after threatening to take control of its oil industry.
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a month
The Sensex ended marginally higher, while four BSE 200 stocks touched fresh 52-week highs, signaling strong investor confidence. Zydus Lifesciences, Apollo Hospitals, Federal Bank and Adani Ports reached their highest levels in a year, supported by steady recent gains.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.